The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
Cointelegraph.com NewsRead More
Related Posts
Gemini launches campaign finance initiative for pro-crypto candidates
The announcement from Gemini followed $2 million in personal donations from the Winklevoss brothers to former President Trump’s re-election campaign. Cointelegraph.com NewsRead More
OpenAI fears people will forms bonds with the AI it developed to fool humans
The warning shows that developers are aware that anthropomorphization is a legitimate concern in the AI industry. Cointelegraph.com NewsRead More
CEX listings outperform Nasdaq and Dow IPOs with 80% average returns
Cryptocurrency listings have outperformed the average of traditional stock listings, despite recent community criticism regarding the manipulation potential of token listings on centralized exchanges. Token […]
